Stable reporter cell lines for peroxisome proliferator-activated receptor γ (PPARγ)-mediated modulation of gene expression.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Analytical Biochemistry

• Publication date

  2011-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ab.2011.02.032PMID 21354099
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Culinary plants, herbs and spices – A rich source of PPARγ ligands

  2009cited by this paper
• Peroxisome Proliferator-Activated Receptor γ Pathway Targeting in Carcinogenesis: Implications for Chemoprevention

  2009cited by this paper
• Potential of Peroxisome Proliferator-Activated Receptor Gamma Antagonist Compounds as Therapeutic Agents for a Wide Range of Cancer Types

  2008cited by this paper
• PPARγ1 as a Molecular Target of Eicosapentaenoic Acid in Human Colon Cancer (HT-29) Cells

  2008cited by this paper
• The many faces of PPARgamma: anti-inflammatory by any means?

  2008cited by this paper
• Thiazolidinediones: effects on insulin resistance and the cardiovascular system

  2008cited by this paper
• PPARγ agonists as therapeutics for the treatment of Alzheimer’s disease

  2008cited by this paper
• Molecular mechanism of PPAR in the regulation of age-related inflammation.

  2008cited by this paper
• PPARgamma1 as a molecular target of eicosapentaenoic acid in human colon cancer (HT-29) cells.

  2008cited by this paper
• Peroxisome proliferator-activated receptors (PPARs) and their agonists for hypertension and heart failure: are the reagents beneficial or harmful?

  2008cited by this paper
• Recent thiazolidinediones as antidiabetics

  2007cited by this paper
• A fluorescent indicator to visualize ligand-induced receptor/coactivator interactions for screening of peroxisome proliferator-activated receptor gamma ligands in living cells.

  2007cited by this paper
• Peroxisome proliferator-activated receptor &ggr;: a novel target for cancer therapeutics?

  2007cited by this paper
• Present concepts and future outlook: Function of peroxisome proliferator‐activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer

  2007cited by this paper
• Investigation of the lipophilic behaviour of some thiazolidinediones. Relationships with PPAR-gamma activity.

  2007cited by this paper
• Impaired peroxisome proliferator-activated receptor gamma function through mutation of a conserved salt bridge (R425C) in familial partial lipodystrophy.

  2007cited by this paper
• Actions of peroxisome proliferator-activated receptors-gamma agonists explaining a possible blood pressure-lowering effect.

  2006cited by this paper
• Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation.

  2006cited by this paper
• Synthesis of the PPARbeta/delta-selective agonist GW501516 and C4-thiazole-substituted analogs.

  2006cited by this paper
• Can PPARgamma agonists have a role in the management of obesity-related hypertension?

  2006cited by this paper
• Synthesis of the PPARβ/δ-selective agonist GW501516 and C4-thiazole-substituted analogs

  2006cited by this paper
• Identification of putative metabolites of docosahexaenoic acid as potent PPARgamma agonists and antidiabetic agents.

  2005cited by this paper
• Differential responses of PPARα, PPARδ, and PPARγ reporter cell lines to selective PPAR synthetic ligands

  2005cited by this paper
• Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands.

  2005cited by this paper
• The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoform.

  2005cited by this paper
• Prediction of PPAR-alpha ligand-mediated physiological changes using gene expression profiles.

  2004cited by this paper
• Peroxisome-proliferator-activated receptors and cancers: complex stories

  2004cited by this paper
• Alpha-Lipoic acid-based PPARgamma agonists for treating inflammatory skin diseases.

  2004cited by this paper
• Prediction of PPAR-α ligand-mediated physiological changes using gene expression profiles Published, JLR Papers in Press, December 16, 2003. DOI 10.1194/jlr.M300239-JLR200

  2004cited by this paper
• Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays.

  2004cited by this paper
• Thiazolidinediones.

  2004cited by this paper
• Pioglitazone Prevents Hypertension and Reduces Oxidative Stress in Diet-Induced Obesity

  2004cited by this paper
• Review: Peroxisome Proliferator-Activated Receptor-γ and Its Role in the Development and Treatment of Diabetes

  2004cited by this paper
• A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist.

  2004cited by this paper
• α-Lipoic acid-based PPARγ agonists for treating inflammatory skin diseases

  2004cited by this paper
• Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activity.

  2003cited by this paper
• Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation

  2003cited by this paper
• Modulation of PPARγ activity with pharmaceutical agents: Treatment of insulin resistance and atherosclerosis

  2003cited by this paper
• Novel selective small molecule agonists for peroxisome proliferator-activated receptor δ (PPARδ)—synthesis and biological activity

  2003cited by this paper
• Thiazolidinediones and type 2 diabetes: new drugs for an old disease

  2002cited by this paper
• Genetic analysis of adipogenesis through peroxisome proliferator-activated receptor gamma isoforms.

  2002cited by this paper
• The mechanisms of action of PPARs.

  2002cited by this paper
• Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.

  2002cited by this paper
• T0070907, a Selective Ligand for Peroxisome Proliferator-activated Receptor γ, Functions as an Antagonist of Biochemical and Cellular Activities*

  2002cited by this paper
• PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis.

  2002cited by this paper
• Troglitazione affects survival of human osteosarcoma cells

  2002cited by this paper
• Genetic Analysis of Adipogenesis through Peroxisome Proliferator-activated Receptor γ Isoforms*

  2002cited by this paper
• PPARγ knockdown by engineered transcription factors: exogenous PPARγ2 but not PPARγ1 reactivates adipogenesis

  2002cited by this paper
• Nuclear hormone receptors and gene expression.

  2001cited by this paper
• 4-hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta.

  2001cited by this paper
• A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport

  2001cited by this paper
• 4-Hydroxytamoxifen Trans-Represses Nuclear Factor-κB Activity in Human Osteoblastic U2-OS Cells through Estrogen Receptor (ER)α, and Not through ERβ.

  2001cited by this paper
• Roles of PPARs in health and disease

  2000cited by this paper
• The PPARs: from orphan receptors to drug discovery.

  2000influential reference
• Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions.

  1999cited by this paper
• PPAR gamma is required for placental, cardiac, and adipose tissue development.

  1999cited by this paper
• PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development

  1999cited by this paper
• The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.

  1998cited by this paper
• PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines.

  1998cited by this paper
• N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents.

  1998cited by this paper
• Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells.

  1998cited by this paper
• Identification of High-Affinity Binding Sites for the Insulin Sensitizer Rosiglitazone (BRL-49653) in Rodent and Human Adipocytes Using a Radioiodinated Ligand for Peroxisomal Proliferator-Activated Receptor γ

  1998cited by this paper
• Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

  1998cited by this paper
• Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

  1998cited by this paper
• The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation

  1998cited by this paper
• Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators

  1998cited by this paper
• Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma.

  1998cited by this paper
• A Potent Antidiabetic Thiazolidinedione with Unique Peroxisome Proliferator-activated Receptor γ-activating Properties*

  1998cited by this paper
• PPAR-γ agonists inhibit production of monocyte inflammatory cytokines

  1998cited by this paper
• Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ

  1997cited by this paper
• Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.

  1997cited by this paper
• Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay.

  1997cited by this paper
• Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta.

  1997cited by this paper
• Ligand-independent Activation Domain in the N Terminus of Peroxisome Proliferator-activated Receptor γ (PPARγ)

  1997cited by this paper
• Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin.

  1997cited by this paper
• The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene*

  1997cited by this paper
• The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones.

  1996cited by this paper
• Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2.

  1996cited by this paper
• The PPARalpha-leukotriene B4 pathway to inflammation control.

  1996cited by this paper
• Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.

  1996cited by this paper
• Molecular Cloning, Expression and Characterization of Human Peroxisome Proliferator Activated Receptors γ1 and γ2

  1996cited by this paper
• The PPARα–leukotriene B4 pathway to inflammation control

  1996cited by this paper
• The structure - Activity relationship between peroxisome proliferator-activated receptor γ agonism and the antihyperglycemic activity of thiazolidinediones

  1996cited by this paper
• A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.

  1995cited by this paper
• 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.

  1995cited by this paper
• 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ

  1995cited by this paper
• An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).

  1995cited by this paper
• An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*)

  1995cited by this paper
• Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor.

  1994cited by this paper
• mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.

  1994cited by this paper

• Comparative in vitro assessment of bioactive chemicals in wastewater from South Australia and Oman using reporter gene assays and a fish cell line.

  2025cites this paper
• A data-derived reference mixture representative of European wastewater treatment plant effluents to complement mixture assessment.

  2023cites this paper
• Evaluation of a full-scale wastewater treatment plant with ozonation and different post-treatments using a broad range of in vitro and in vivo bioassays.

  2022cites this paper
• Assessing Performance of Wastewater Treatment Using in Vitro Cell-based Assays

  2021cites this paper
• A bioimaging system combining human cultured reporter cells and planar chromatography to identify novel bioactive molecules.

  2021cites this paper
• Helix 12 stabilization contributes to basal transcriptional activity of PXR

  2021cites this paper
• Adipogenic Activity of Chemicals Used in Plastic Consumer Products

  2021cites this paper
• Assessing Indoor Dust Interference with Human Nuclear Hormone Receptors in Cell-Based Luciferase Reporter Assays

  2021cites this paper
• Reporter gene comparison demonstrates interference of complex body fluids with secreted luciferase activity

  2021cites this paper
• Effect-directed analysis and chemical identification of agonists of peroxisome proliferator-activated receptors in white button mushroom.

  2020cites this paper
• Endocrine activities of phthalate alternatives; assessing the safety profile of furan dicarboxylic acid esters using a panel of human cell based reporter gene assays

  2020cites this paper
• Induction of peroxisome proliferator activated receptor γ (PPARγ) mediated gene expression and inhibition of induced nitric oxide production by Maerua subcordata (Gilg) DeWolf

  2020cites this paper
• Using bioanalytical tools to detect and track organic micropollutants in the Ganga River near two major cities.

  2020cites this paper
• Combining In Vitro Data and Physiologically Based Kinetic Modeling Facilitates Reverse Dosimetry to Define In Vivo Dose–Response Curves for Bixin‐ and Crocetin‐Induced Activation of PPARγ in Humans

  2019cites this paper
• Assessment of total, ligand-induced peroxisome proliferator activated receptor γ ligand activity in serum

  2019cites this paper
• Identification of PPAR-activating compounds in herbal and edible plants and fungi from Vietnam

  2019cites this paper
• Testing comparability of existing and innovative bioassays for water quality assessment

  2019influential citation
• Sustained relief of trigeminal neuropathic pain by a blood–brain barrier penetrable PPAR gamma agonist

  2019cites this paper
• Effects of Flavored Nonalcoholic Beverages on Transcriptional Activities of Nuclear and Steroid Hormone Receptors: Proof of Concept for Novel Reporter Cell Line PAZ-PPARg.

  2018cites this paper
• In vitro nuclear receptor inhibition and cytotoxicity of hydraulic fracturing chemicals and their binary mixtures.

  2018cites this paper
• Effect-based trigger values for in vitro and in vivo bioassays performed on surface water extracts supporting the environmental quality standards (EQS) of the European Water Framework Directive.

  2018cites this paper
• Stable cellular models of nuclear receptor PXR for high-throughput evaluation of small molecules.

  2018cites this paper
• Using bisphenol A and its analogs to address the feasibility and usefulness of the CALUX-PPARγ assay to identify chemicals with obesogenic potential.

  2018cites this paper
• In vitro bioassays to evaluate beneficial and adverse health effects of botanicals: promises and pitfalls.

  2017cites this paper
• Corrosion protection products as a source of bisphenol A and toxicity to the aquatic environment.

  2017cites this paper
• Screening of molecular cell targets for carcinogenic heterocyclic aromatic amines by using CALUX® reporter gene assays

  2017cites this paper
• Endocrine Disruption and In Vitro Ecotoxicology: Recent Advances and Approaches.

  2017cites this paper
• New Transcriptional Reporters to Quantify and Monitor PPARγ Activity

  2017cites this paper
• PPARγ affects nitric oxide in human umbilical vein endothelial cells exposed to Porphyromonas gingivalis.

  2016cites this paper
• Endocrine activity of mycotoxins and mycotoxin mixtures.

  2016cites this paper
• Tracking multiple modes of endocrine activity in Australia's largest inland sewage treatment plant and effluent‐ receiving environment using a panel of in vitro bioassays

  2015cites this paper
• Various peroxisome proliferator‐activated receptor (PPAR)‐γ agonists differently induce differentiation of cultured human keratinocytes

  2015cites this paper
• The effect of quercetin and kaempferol aglycones and glucuronides on peroxisome proliferator-activated receptor-gamma (PPAR-γ).

  2015cites this paper
• Reporter Cell Lines for the Characterization of the Interactions between Human Nuclear Receptors and Endocrine Disruptors

  2015influential citation
• Model Steatogenic Compounds (Amiodarone, Valproic Acid, and Tetracycline) Alter Lipid Metabolism by Different Mechanisms in Mouse Liver Slices

  2014cites this paper
• Development of a panel of high-throughput reporter-gene assays to detect genotoxicity and oxidative stress.

  2014cites this paper
• Assessment of multiple hormonal activities in wastewater at different stages of treatment

  2014cites this paper
• Benchmarking organic micropollutants in wastewater, recycled water and drinking water with in vitro bioassays.

  2014cites this paper
• Induction of peroxisome proliferator-activated receptor γ (PPARγ)-mediated gene expression by tomato (Solanum lycopersicum L.) extracts.

  2013cites this paper
• Similarities in the endocrine-disrupting potencies of indoor dust and flame retardants by using human osteosarcoma (U2OS) cell-based reporter gene assays.

  2013cites this paper
• A Panel of Quantitative Calux® Reporter Gene Assays for Reliable High‐Throughput Toxicity Screening of Chemicals and Complex Mixtures

  2013cites this paper
• Modulation of Canonical Wnt Signalling in Mesenchymal Stem Cells using a GSK3beta Inhibitor

  2013cites this paper
• In vitro reporter gene assays for assessment of PPAR- and Nrf2-mediated health effects of tomato and its bioactive constituents

  2013cites this paper
• Dr‐Calux®: A High‐Throughput Screening Assay for the Detection of Dioxin and Dioxin‐Like Compounds in Food and Feed.

  2013cites this paper
• Correlation between activation of PPARγ and resistin downregulation in a mouse adipocyte cell line by a series of thiazolidinediones.

  2013cites this paper
• Short-Chain Fatty Acids Stimulate Angiopoietin-Like 4 Synthesis in Human Colon Adenocarcinoma Cells by Activating Peroxisome Proliferator-Activated Receptor γ

  2013cites this paper
• Induction of electrophile-responsive element (EpRE)-mediated gene expression by tomato extracts in vitro.

  2012cites this paper
• A Novel RNAi Lethality Rescue Screen to Identify Regulators of Adipogenesis

  2012cites this paper
• Chapter 1. General Introduction Why Focus on Water Quality? Pathways Relevant for Water Quality Assessment

  year unknowncites this paper